// App-Quantinova.ai

OP0197 : THE INITIAL TREATMENT OF SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS: AN INTERNATIONAL COLLABORATION AMONG 10 REGISTRIES

Researchers

Presenter

  • M. B. Son

Principal Investigators

  • K. Aalto

  • L. Berntson

  • J. Dallas

  • C. Duffy

  • M. Glerup

  • J. Guzman

  • T. Herlin

  • P. Hovi

  • K. Hyrich

  • J. Klotsche

  • B. Magnusson

  • V. Mcityre

  • E. Nordal

  • S. zen

  • M. J. Santos

  • B. Szeri

  • T. Beukelman

Medical Centers

  • Boston Children's Hospital, Boston, United States

  • Hackensack Meridian Health Hackensack University Medical Center, Hackensack, United States of America

  • Childrens Hospital, Helsinki, Finland

  • Uppsala University Hospital, Uppsala, Sweden

  • CHEO, Ottawa, Canada

  • Skejby Sygehus, Aarhus, Denmark

  • The University of British Columbia, Vancouver, BC, Canada

  • BC Children's Hospital, Vancouver, BC, Canada

  • University of Manchester, Manchester, United Kingdom

  • Manchester University NHS FT, Manchester, United Kingdom

  • Deutsches Rheumaforschungszentrum, Berlin, Germany

  • Karolinska University Hospital, Stockholm, Sweden

  • The Arctic University of Norway, Troms, Norway.

  • Hacettepe Üniversitesi Tip Fakültesi, Ankara, Turkey

  • Hospital Garcia de Orta, Almada, Portugal

  • Ankara University Institute of Health Sciences, Ankara, Turkey

  • University of Alabama at Birmingham, Birmingham, Alabama, United States

Locations

  • United States

  • Finland

  • Sweden

  • Canada

  • Denmark

  • United Kingdom

  • Germany

  • Norway

  • Turkey

  • Portugal

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Rheumatoid arthritis

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • Multinational

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • Pfizer

Result

  • N/A